FDA in­spec­tion at In­dia phar­ma at cen­ter of the cis­platin short­age cites mul­ti­ple qual­i­ty is­sues

An FDA in­spec­tion of the In­tas Phar­ma­ceu­ti­cals man­u­fac­tur­ing fa­cil­i­ty in In­dia that pro­duces the can­cer drug cis­platin, now in short sup­ply, found in­stances of ma­nip­u­lat­ed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER